For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

The high cost of prescription drugs in America has again moved back into the political spotlight, with President Trump recently signing an executive order aimed at bringing prices more in line with ...

President Trump proposed a plan to lower prescription drug prices, focusing on the "Most Favored Nation" executive order. The plan aims to address the disparity in drug prices between the U.S. and ...

President Donald Trump is ramping up the heat on pharmaceutical companies, urging them in letters sent Thursday to cut down drug prices in accordance with an executive order he signed in May. But ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. President Trump is also looking to revive some of the ...

Guest columnists Steve Stivers and Eddie Pauline are probably right that prescription drug price controls are a bad idea ("Ohio’s bioscience boom threatened by MFN price controls,“ July 13). Yet, they ...

A Parliamentary panel has flagged that a substantial segment of cancer drugs are still beyond the ambit of current price control mechanisms and recommended measures to include the widest possible ...

The MFN executive order seeks to align US drug prices with those in other developed countries, recently advancing through a voluntary agreement with Pfizer. Legal and procedural challenges exist, with ...

In May, President Donald Trump signed an executive order to combat high drug prices by establishing a most-favored nation policy. The president is correct to seek to lower drug prices, as the U.S. has ...

President Donald Trump signs an executive order on Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients at a press conference with Health and Human Services Secretary Robert F ...